Discovering and Developing Molecules with Optimal Drug-Like Properties (eBook)

Artikelnummer: 978-1-4939-1399-2
Einband: PDF
Verfügbarkeit: Download, sofort verfügbar (Link per E-Mail)
CHF 236.00
decrease increase

This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state propertiesand critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings.


This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state propertiesand critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings.


Schreiben Sie Ihre eigene Bewertung
  • Nur registrierte Benutzer können Produkte bewerten
*
*
Schlecht
Sehr gut
*
*
*
*
VerlagSpringer New York
EinbandPDF
Erscheinungsjahr2014
Seitenangabe511 S.
AusgabekennzeichenEnglisch
AbbildungenXI, 511 p. 161 illus., 130 illus. in color.
Masse12'439 KB
PlattformPDF
ReiheAAPS Advances in the Pharmaceutical Sciences Series
AutorTempleton, Allen C (Hrsg.) / Byrn, Stephen R. (Hrsg.) / Haskell, Roy J (Hrsg.) / Prisinzano, Thomas E. (Hrsg.)

Alle Bände der Reihe "AAPS Advances in the Pharmaceutical Sciences Series"

Über den Autor Allen C (Hrsg.) Templeton

203849775

Weitere Titel von Allen C (Hrsg.) Templeton

Produktbewertungen
Nur registrierte Benutzer können Produkte bewerten